Medigen Vaccine Biologics (6547) — Net Asset Quality Index
Medigen Vaccine Biologics (6547) has a Net Asset Quality Index of 74.7% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of NT$4.76 Billion minus total liabilities of NT$1.21 Billion yields net assets of NT$3.56 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Medigen Vaccine Biologics (6547) financial obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Medigen Vaccine Biologics Net Asset Quality Index Over Time (2012–2025)
This chart shows how Medigen Vaccine Biologics's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the index stands at 74.7%, representing net assets of NT$3.56 Billion against total assets of NT$4.76 Billion TWD. For live market cap and overall valuation, see 6547 company net worth.
Annual Net Asset Quality Index for Medigen Vaccine Biologics (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Medigen Vaccine Biologics from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check 6547 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (TWD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 88.4% | NT$3.48 Billion | NT$3.93 Billion | NT$454.64 Million | ▲ +0.2 pp |
| 2024 | 88.2% | NT$3.85 Billion | NT$4.36 Billion | NT$513.92 Million | ▲ +25.1 pp |
| 2023 | 63.1% | NT$3.85 Billion | NT$6.09 Billion | NT$2.25 Billion | ▼ -5.3 pp |
| 2022 | 68.4% | NT$5.03 Billion | NT$7.35 Billion | NT$2.32 Billion | ▼ -19.8 pp |
| 2021 | 88.2% | NT$4.68 Billion | NT$5.30 Billion | NT$622.95 Million | ▼ -1.7 pp |
| 2020 | 90.0% | NT$3.14 Billion | NT$3.49 Billion | NT$349.40 Million | ▲ +30.0 pp |
| 2019 | 60.0% | NT$1.37 Billion | NT$2.28 Billion | NT$910.28 Million | ▼ -13.8 pp |
| 2018 | 73.8% | NT$1.61 Billion | NT$2.18 Billion | NT$571.10 Million | ▲ +2.6 pp |
| 2017 | 71.2% | NT$1.52 Billion | NT$2.14 Billion | NT$615.41 Million | ▼ -9.7 pp |
| 2016 | 80.9% | NT$1.47 Billion | NT$1.82 Billion | NT$347.90 Million | ▼ -0.4 pp |
| 2015 | 81.3% | NT$1.34 Billion | NT$1.65 Billion | NT$309.19 Million | ▼ -7.5 pp |
| 2014 | 88.8% | NT$1.08 Billion | NT$1.21 Billion | NT$135.95 Million | ▼ -7.1 pp |
| 2013 | 95.9% | NT$457.94 Million | NT$477.40 Million | NT$19.46 Million | ▲ +10.7 pp |
| 2012 | 85.2% | NT$128.00 Million | NT$150.15 Million | NT$22.15 Million | — |